Ex Vivo Treatment with a Novel Synthetic Aminoglycoside NB54 in Primary Fibroblasts from Rett Syndrome Patients Suppresses MECP2 Nonsense Mutations

BACKGROUND: Nonsense mutations in the X-linked methyl CpG-binding protein 2 (MECP2) comprise a significant proportion of causative MECP2 mutations in Rett syndrome (RTT). Naturally occurring aminoglycosides, such as gentamicin, have been shown to enable partial suppression of nonsense mutations rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Vecsler, Manuela, Ben Zeev, Bruria, Nudelman, Igor, Anikster, Yair, Simon, Amos J., Amariglio, Ninette, Rechavi, Gideon, Baasov, Timor, Gak, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113846/
https://www.ncbi.nlm.nih.gov/pubmed/21695138
http://dx.doi.org/10.1371/journal.pone.0020733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113846/
https://www.ncbi.nlm.nih.gov/pubmed/21695138
http://dx.doi.org/10.1371/journal.pone.0020733

Ejemplares similares